Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,424.85 162.29 1.00%
S&P 500 1,862.31 19.33 1.05%
NASDAQ 4,086.22 52.06 1.29%
Ticker Volume Price Price Delta
STOXX 50 3,139.26 47.74 1.54%
FTSE 100 6,584.17 42.56 0.65%
DAX 9,317.82 144.11 1.57%
Ticker Volume Price Price Delta
NIKKEI 14,417.68 420.87 3.01%
TOPIX 1,166.55 30.46 2.68%
HANG SENG 22,696.01 24.75 0.11%

Stock Movements and Upcoming Healthcare Conferences - Research Report on HCP, Health Care REIT, DaVita, IDEXX Laboratories, and



Stock Movements and Upcoming Healthcare Conferences - Research Report on HCP,
          Health Care REIT, DaVita, IDEXX Laboratories, and Thoratec

Editor Note: For more information about this release, please scroll to bottom

PR Newswire

NEW YORK, January 10, 2014

NEW YORK, January 10, 2014 /PRNewswire/ --

Today, Analysts' Corner announced new research reports highlighting HCP, Inc.
(NYSE: HCP), Health Care REIT, Inc. (NYSE: HCN), DaVita HealthCare Partners
Inc. (NYSE: DVA), IDEXX Laboratories, Inc. (NASDAQ: IDXX), and Thoratec Corp.
(NASDAQ: THOR). Today's readers may access these reports free of charge -
including full price targets, industry analysis and analyst ratings - via the
links below.

HCP, Inc. Research Report

On January 7, 2014, HCP, Inc.'s (HCP) stock increased 1.71%, ending the day at
$37.44. Over the previous three trading sessions, shares of HCP rose 3.40%,
compared to the Dow Jones Industrial Average, which gained 0.54% during the
same period. The Full Research Report on HCP, Inc. - including full detailed
breakdown, analyst ratings and price targets - is available to download free
of charge at:

http://www.AnalystsCorner.com/r/full_research_report/6c26_HCP

--

Health Care REIT, Inc. Research Report

On January 7, 2014, Health Care REIT, Inc.'s (Health Care REIT) stock declined
0.06%, ending the day at $54.26. Over the previous three trading sessions,
shares of Health Care REIT increased 1.34%, compared to the Dow Jones
Industrial Average which gained 0.54% during the same period. The Full
Research Report on Health Care REIT, Inc. - including full detailed breakdown,
analyst ratings and price targets - is available to download free of charge
at:

http://www.AnalystsCorner.com/r/full_research_report/cf1e_HCN

--

DaVita HealthCare Partners Inc. Research Report

On January 7, 2014, DaVita HealthCare Partners Inc.'s (DaVita) stock rose
0.62%, ending the day at $65.20. Over the previous three trading sessions,
shares of DaVita increased 0.65%, compared to the Dow Jones Industrial Average
went up by 0.54% during the same period. The Full Research Report on DaVita
HealthCare Partners Inc. - including full detailed breakdown, analyst ratings
and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/5986_DVA

--

IDEXX Laboratories, Inc. Research Report

On January 6, 2014, IDEXX Laboratories, Inc. (IDEXX) announced that it will
take part in the 32^nd Annual J.P. Morgan Healthcare Conference. The Company
added that its Chairman and CEO, Jonathan Ayers, will give a presentation on
IDEXX on Monday, January 13, 2014 at 3:30 p.m. PST, at the Westin St. Francis
Hotel, San Francisco, California. IDEXX stated that a live audio webcast of
the presentation can be accessed via its website, where an archived edition of
the presentation will also be available for 14 days. The Full Research Report
on IDEXX Laboratories, Inc. - including full detailed breakdown, analyst
ratings and price targets - is available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/bf62_IDXX

--

Thoratec Corp. Research Report

On December 19, 2013, Thoratec Corp. (Thoratec) announced its participation in
the 32^nd Annual JP Morgan Healthcare Conference on January 13, 2014. The
Company stated that its President and CEO, Gary F. Burbach, will give an
update on the Company, starting at 8:00 a.m. PST/ 11:00 a.m. EST. Thoratec
added that the presentation and subsequent breakout session can be accessed
through the Company website. The Full Research Report on Thoratec Corp. -
including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:

http://www.AnalystsCorner.com/r/full_research_report/1bee_THOR

----

EDITOR NOTES:

 1. This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
 2. Information in this release is fact checked and produced on a best efforts
    basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are
    only human and are prone to make mistakes. If you notice any errors or
    omissions, please notify us below.
 3. This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.

 1. If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
 2. For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
 3. Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Nidhi Vatsal, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.

SOURCE Analysts' Corner

Contact: CONTACT PERSON: Joe Thomas CONTACT PHONE: +1-310-496-8071 (North
America)
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement